Skip to main content
. 2010 Jun 1;32(4):521–534. doi: 10.1007/s11357-010-9154-8

Table 1.

Baseline characteristics by survival and morbidity status (n = 2,008)

Not survived Survived to 85
Total (n = 639) Total (n = 1,369) With morbidity (n = 409) Morbidity-free 1 (n = 960)
Demographic and lifestyle
 Sex (female) 343 (53.7) 981 (71.7) 269 (65.8) 712 (74.2)
 Education (range 1–7) 3.00 ± 1.85 2.94 ± 1.84 2.98 ± 1.82 2.92 ± 1.85
 Relatives (number of relatives) 8.40 (3.47) 8.78 (3.64) 8.85 (3.66) 8.75 (3.63)
 Spousal death (absent) 570 (89.2) 1,266 (92.5) 383 (93.6) 883 (92.0)
 Living status (with partner) 228 (35.7) 635 (46.4) 164 (40.1) 471 (49.1)
 Income (euro per month) 1,884.64 ± 750.11 1,806.31 ± 814.86 1,804.40 ± 922.51 1,807.13 ± 764.94
 Health insurance (private) 278 (43.5) 498 (36.4) 150 (36.7) 348 (36.3)
 Body mass index (kg/m2) 26.10 ± 3.60 26.59 ± 3.73 26.74 ± 3.79 26.53 ± 3.70
 Energy intake (kJ/day) 8,340.75 ± 1,709.88 7,903.31 ± 1,623.01 7,972.80 ± 1,602.31 7,873.70 ± 1,631.67
 Fruit and vegetable intake (g/day) 556.71 ± 151.42 563.98 ± 168.68 561.74 ± 162.91 564.93 ± 171.15
 Alcohol (g/day) 9.84 ± 13.29 7.33 ± 10.61 8.01 ± 11.28 7.04 ± 10.31
 Smoking (non-smoker) 207 (32.4) 691 (50.5) 201 (49.1) 490 (51.0)
Health and morbidity indicators
 Diabetes mellitus (absent) 558 (87.3) 1,206 (88.1) 348 (85.1) 858 (89.4)
 Medication usage (number of medications) 2.38 ± 2.25 2.15 ± 2.06 2.28 ± 2.15 2.09 ± 2.01
 Anti-hypertensive use (none recorded) 539 (84.4) 1,196 (87.4) 352 (86.1) 844 (87.9)
 Left ventricular function (normal) 591 (92.5) 1,328 (97.0) 392 (95.8) 936 (97.5)
 Atrial fibrillation (absent) 614 (96.1) 1,330 (97.2) 399 (97.6) 931 (97.0)
 Family history (free from morbidity) 315 (49.3) 651 (47.6) 187 (45.7) 464 (48.3)
 Depression history (no events recorded) 453 (70.9) 957 (69.9) 274 (67.0) 683 (71.1)
 Hospitalisation (none past 12 months) 517 (80.9) 1,137 (83.1) 340 (83.1) 797 (83.0)
 Hip function (absence of fractures) 627 (98.1) 1,347 (98.4) 402 (98.3) 945 (98.4)
 Vertebral function (absence of fractures) 610 (95.5) 1,271 (92.8) 385 (94.1) 886 (92.3)
 Self-rated health (1: worse to 3: better) 2.35 ± 0.68 2.51 ± 0.61 2.44 ± 0.62 2.53 ± 0.60
 Cognitive status (intact: MMSE ≥ 26) 531 (83.1) 1,183 (86.4) 345 (84.4) 838 (87.3)
 Memory (no problems reported) 591 (92.5) 1,302 (95.1) 381 (93.2) 921 (95.9)
 ADL (unimpaired: HAQ score ≤ 0.5) 417 (65.3) 918 (67.1) 269 (65.8) 649 (67.6)
 IADL (unimpaired: IADL score <1.0) 503 (78.7) 1,180 (86.2) 351 (85.8) 829 (86.4)
 Stability in body weight (past 12 months) 546 (85.4) 1,222 (89.3) 369 (90.2) 853 (88.9)
Physiological markers
 Leucocytes (109/l) 7.07 ± 3.32 6.66 ± 1.80 6.76 ± 1.79 6.62 ± 1.80
 C-reactive protein (g/l) 4.39 ± 5.53 3.05 ± 4.66 3.12 ± 4.72 3.02 ± 4.64
 Glucose (mmol/l) 7.12 ± 2.70 6.97 ± 2.77 7.19 ± 3.33 6.87 ± 2.49
 Albumin (g/l) 42.12 ± 2.34 42.40 ± 2.26 42.69 ± 2.21 42.28 ± 2.28
 Creatinine (µmol/l) 85.66 ± 21.77 82.26 ± 13.65 83.62 ± 14.76 81.68 ± 13.11
 Uric acid (µmol/l) 330.50 ± 73.08 316.58 ± 67.99 324.99 ± 70.43 313.00 ± 66.63
 Total cholesterol (mmol/l) 6.46 ± 1.27 6.66 ± 1.17 6.64 ± 1.16 6.67 ± 1.17
 HDL cholesterol (mmol/l) 1.34 ± 0.39 1.37 ± 0.34 1.35 ± 0.35 1.38 ± 0.34
 Systolic blood pressure (mmHg) 144.54 ± 22.03 144.21 ± 20.41 147.36 ± 19.64 142.87 ± 20.60
 Diastolic blood pressure (mmHg) 73.76 ± 11.67 72.48 ± 10.81 73.50 ± 11.13 72.04 ± 10.65
 Heart rate (median RR interval) 72.52 ± 11.68 72.21 ± 10.31 72.11 ± 10.29 72.25 ± 10.33
 Femoral neck bone mineral density (g/cm2) 0.80 ± 0.12 0.80 ± 0.12 0.81 ± 0.12 0.79 ± 0.13
 Lumbar spine bone mineral density (g/cm2) 1.09 ± 0.19 1.07 ± 0.19 1.08 ± 0.19 1.06 ± 0.19
 Ankle brachial index (ratio) 1.02 ± 0.23 1.04 ± 0.22 1.02 ± 0.22 1.05 ± 0.22
 Aortic calcification (plaque length 0–5) 2.18 ± 1.27 2.10 ± 1.29 2.23 ± 1.31 2.04 ± 1.28
 Intima media thickness (mm) 0.88 ± 0.14 0.86 ± 0.12 0.88 ± 0.12 0.86 ± 0.12
 Carotid plaques (plaque sites 0–6) 2.02 ± 1.64 1.72 ± 1.50 1.89 ± 1.54 1.65 ± 1.48

Values are mean ± SD or n (%). All values are from baseline measurements

MMSE Mini Mental State Examination, ADL activities of daily living, HAQ Health Assessment Questionnaire, IADL instrumental activities of daily living